Moderna (MRNA) shares continued to rise in the premarket on Wednesday as analysts argued that the company’s agreement to resolve a patent dispute with Arbutus Biopharma (ABUS) and the Roivant unit ...
Moderna Inc (NASDAQ:MRNA) stock is trading higher Wednesday afternoon, lifted by positive sentiment across the pharmaceutical sector. The rally follows a landmark agreement Tuesday between Pfizer Inc ...
Moderna Inc. MRNA shares are up on Wednesday as the company has received positive news regarding its investigational flu vaccine, mRNA-1010. The stock’s movement comes after the U.S. Food and Drug ...
Hosted on MSN
Moderna stock jumps 10% after hours: Here's why
Moderna Inc MRNA shares are rising in Tuesday’s after-hours session after the company announced it reached a settlement agreement with Arbutus Biopharma and Genevant Sciences. Moderna announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results